As part of the transaction, the manufacturing operations, sterilization services, warehouse facilities, R&D and regulatory support functions located in Gargrave have been transferred to Scapa Healthcare.
Scapa Healthcare recently announced it has completed the acquisition of the Systagenix manufacturing facility located in Gargrave, England, from Acelity. As part of the transaction, the manufacturing operations, sterilization services, warehouse facilities, R&D and regulatory support functions located in Gargrave have been transferred to Scapa Healthcare.
Scapa Healthcare and Acelity have entered into a long-term exclusive manufacturing and supply agreement, in which Scapa Healthcare will reportedly continue manufacturing the KCI advanced wound-dressings portfolio manufactured in Gargrave.